CLINICAL_TRIALS
trial_result
· 2017-02-24
Clinical Trial Update: Caffeine/Propranolol Intervention for Acute Migraine [Phase 2]
Summary
Phase 2 trial evaluating a caffeine and propranolol combination for acute migraine has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Migraine Disorders | Phase 2 | Status: COMPLETED | Results posted: 2017-02-24